Drugmaker Endo Misses Bond Payment As Potential Bankruptcy Looms
(Bloomberg) -- Endo International Plc, the latest drugmaker pushed to the brink by opioid lawsuits, said it skipped a $38 million interest payment as it looks at options including a potential bankruptcy filing.
The move, which affects the company's unsecured bonds, means the company sided with senior creditors, who have argued that skipping the bond payment and reorganizing in bankruptcy is better for the company. Endo has 30 days to hand over the missing cash before it becomes a formal default. The company chose to skip the payment while it keeps talking to creditors about ways to ease its debt load, Endo said in a regulatory filing.
The company has been discussing its options with creditor groups that have conflicting views over its best path for dealing with lawsuits over its role in America's opioid epidemic, a mounting debt load and a dimmed outlook for its bestselling drug.
The company's senior lenders favor bankruptcy and wanted the company to skip upcoming interest payments to preserve cash, according to people with knowledge of the talks. Endo's lower-ranking creditors are pressing options that would restrucuture its debts outside of court.
Before Endo skipped the payment, Bloomberg Intelligence credit analyst Mike Holland said the company was probably looking hard at taking such a step, because Endo has vastly reduced earnings expectations following competition for its top drug, Vasostrict.
“To the dismay of vocal junior bondholders, it appears likely secured lenders and secured bondholders will be in position to drive a possible restructuring process,” Holland said earlier this week.
Representatives of Endo did not return calls and emails seeking comment.
More stories like this are available on bloomberg.com
©2022 Bloomberg L.P.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.